9 Jaw-Dropping Divorce Details Erika Jayne Revealed on 'RHOBH' – Decider

“Yeah, so my life drastically changed this week,” Erika Jayne announced to the group of women on The Real Housewives of Beverly Hills, and she wasn’t lying. The most recent episode of the Bravo series takes place during Sutton’s Paris-themed lunch, the first time the women saw Erika since the news broke in November on Election Day 2020 that she had filed for divorce from husband Tom Girardi.

We’ve been promised that Erika will be mentioning it all this season on the show, but with his ongoing legal troubles, how much could she really say? Well, if this episode is any indication, a lot. Especially when it comes to the divorce, their marriage, and how she is starting her new life.

Here are the nine wildest revelations Erika shared with her friends:

1. What she left behind 

“I let go of my Lamborghini, I let go of my 16,000 sq ft home, I let go of my marriage, I let go of everything,” she tells the table of women. “I literally made a decision that I had to.” On the bright side, she did get herself a new car in the form of a Range Rover.

“I left because he pushed me further and further out,” she explains about the end of her marriage to Tom. “I had to make a choice to do what was right for me, I couldn’t live that way anymore.”

2. Why she couldn’t tell a soul

“None of you knew on purpose because it would put you in a bad position if I were to give you information that you had to hold and I didn’t want to do that and that’s the truth,” she tells the group, which explains their complete shock when she previously texted them the news.

“It also doesn’t serve me to talk a lot about what is happening legally, or will happen legally, because I am married to somebody who’s very good in that area,” she said, and the other women could only nod and understand the position she was in.

“I struggled for a long time knowing that had to leave, but once I made my decision, spent a good 30 days closing out certain parts of my life,” Erika continued, as we see her selling some of her gorgeous clothes. “I cried every day. This was the end of a massive part of my life and stepping into basically a void,” she said, detailing how every time she tried to talk it out with Tom, she was simply “met with such resistance.”

3. The truth about their marriage

“My marriage was never conventional,” Erika admits, though it feels significant now because she always sort of played it off as a relationship that worked for the two of them. Now, we see it did not. “In my marriage, if I wanted to open up and say, ‘You, Tom, have hurt my feelings,’ there was none of that. I was always dismissed.” Oof.

4. Why she filed on Election Day

“I filed on Election Day because I wanted it to get buried,” she confessed in her interview. “I was thinking, this is great, this is the most important historic election in modern times and this is gonna be a blip on the radar. I’ll slide through and nobody will know. Not happening,” she admitted, because we all know that after we performed our civic duty, we texted everyone about the news.

“Just so you know, I keep really good secrets,” she reminded her friends, before then adding, “As soon as I get a handle on what’s coming for me, and it will be coming for me,” which feels all too foreshadowy in this moment.

5. Her new house

“You’re welcome over to my new tiny baby dollhouse,” Erika said to her friends, before revealing that she found it online, and that “it’s a rental, it’s cute.” She also half-whispered that she “stole the furniture” to decorate, before clarifying that she “didn’t take a lot of things” from her old house, but that “I did take a sofa and two chairs. I still don’t have a kitchen table.”

And the way it all went down will give you chills. “I dropped Tom off and work and I went home and moved out. I was out within the day. It’s frightening, you know, when you think about it,” she said quietly.

Her new house is 2015 sq. feet and features 3 bedrooms and 2 bathrooms, which is certainly a change from her former 4 bedrooms and 9 bathrooms. But in this house, one bedroom is for sleeping, one is for clothes, and one is “a shoe palace” that will house her accessories.

6. That traffic story though

In what has to be one of the most revealing stories she’s ever shared about her marriage, not to mention very chilling and the most distinct proof that her strong facade was starting to crack, Erika dropped this truth bomb in her interview. “I’ll never forget one time I was joining Tom and five other guys for dinner. I said, ‘I’m sorry I’m late, I was in traffic,’ and one of them said, ‘Well if you were married to a better man, traffic would be no problem.’ Tom straight looked at him across the table and said, ‘Well if you think you can afford her, you can have her.” My god.

“But I didn’t tell anybody because he supported me when there was nothing,” Erika said. “There always that underlying pressure of wanting to please someone that’s provided for you. I felt always that I should shut up and be grateful to an extent.”

She also goes on to tell Lisa Rinna, “I’ve not felt this vulnerable in maybe ever,” and that “He left me no room and that’s the only way I can say it right now.”

7. How Tom got served

But there are a few other details she can share. “I almost floated the idea of trial separation but I knew it wouldn’t work,” she admitted, knowing that it had to be a “get your shit and go” situation instead.

“I didn’t leave a note,” she stated. “I drove him to work and I told him I loved him and he said, ‘Thanks hun,’ like I was an employee.” And that was the last time she saw him. As she explained, “I went home and started putting everything in the moving van. I drove off, went to my new place, spent the night there, and he was served the next morning. We’re not playing games over here.”

She also very wisely said that she “Expects nothing but the worst and hoping for the best” and that “He’s got some real challenges ahead of him.” Feels like a bit of an understatement at this point.

Erika Jayne on The Real Housewives of Beverly Hills

8. Hot Toddies & THC

In some better news for Erika, she sure does love a hot toddy, as we got to see her drink two this episode, but that’s nothing compared to another liquid. “That little present you gave me, I used it,” she tells Kyle. “I am lit right now. There is this intimate oil that Kyle gifted, it’s THC. She’s been telling us about this oil that she and Mauricio have been enjoying. So I said, hook a girl up, I put it all over my clit and my vajayjay,” she announced to the group to delighted squeals. But Kyle, hook us all up please and let us know which brand you’re using, girl!

9. When she will move on

It’s going to be a long road ahead for Erika as many messy legal battles are still to come, but when it comes to the also messy world of dating, she had a plan. “I’m giving myself 90 days,” she told the group. “No sex. It’s the last thing on my mind, but in 90 days I’m sure I’ll feel different.”

The Real Housewives of Beverly Hills airs Wednesday at 8 pm ET/PT on Bravo. 

Stream The Real Housewives of Beverly Hills on Bravo Now

After Connecticut legalizes marijuana, only 2 New England states now prohibit cannabis – ABC News

After Connecticut Gov. Ned Lamont signed the state legislature’s bill legalizing recreational marijuana on Tuesday, eyes are now on Rhode Island and New Hampshire as the final holdouts in New England to legalize cannabis.

Some marijuana rights advocates told ABC News it’s only a matter of time before the two states join their neighbors, given the millions in extra revenue from marijuana sales and the calls for criminal justice reform from their constituents.

„I think the pressure will be there, being islands of prohibition in the Northeast,” DeVaughn Ward, the senior legislative counsel for the non-profit group the Marijuana Policy Project, told ABC News.

While a vote on a legalization bill in Rhode Island is gaining strength following a passage in its state Senate, advocates on the ground in New Hampshire told ABC News that their state needs extra work.

Still, the marijuana proponents contend, the Connecticut victory greased the wheels in their favor.

Connecticut became the 19th state in the U.S. to legalize recreational marijuana for adults over 21 on Tuesday.

Under Connecticut’s law, which goes into effect July 1, residents over 21 will be able to possess and consume marijuana and state sales are slated to begin next year after the state comes up with its regulation policies. Previous lower-level cannabis records will be expunged as part of the new policy.

Revenue from sales taxes on the substance, expected to be over $100 million annually, will be placed in a „Social Equity and Innovation Fund, which will be used to promote a diverse cannabis industry and reinvest in hard-hit communities,” the Marijuana Policy Project said.

Ward said Connecticut’s law came following years of lobbying and changing views on drug laws by state lawmakers. The successful legalization movements in nearby New Jersey and New York in the last year played the biggest factor, he said.

„You cannot cross state lines with different cannabis laws,” he said. „It would be too complicated and hurt [Connecticut’s] economy.”

Ward said that Connecticut’s passage is what spurred Rhode Island’s legislature to vote on its bill that legalized recreational use. The Rhode Island State Senate passed its version of the bill, which would allow use for adults over 21 and charge a 20% tax, Tuesday night.

Rhode Island’s House of Representatives version of the bill, however, won’t be coming up for a vote before the session ends next week due to a disagreement between lawmakers and Rhode Island Gov. Dan McKee over one technical detail over regulation. The bill currently calls for the creation of an independent Cannabis Control Commission to regulate it, but the governor told reporters Tuesday he wants the state’s Department of Business Regulation to regulate sales.

Nevertheless, Rhode Island House Speaker K. Joseph Shekarchi told ABC News in a statement that it’s possible the House could hold a special session in the summer or fall to address the bill.

„We will take our time and make sure all proposals are carefully vetted and are in the best interest of the State of Rhode Island,” he said in a statement.

Despite the governor’s comments, Ward predicted a „domino effect” brought on by the border states' successes in regulated cannabis will take place this year.

When it comes to New Hampshire, local marijuana legalization advocates contended the conservative state legislature and Gov. Chris Sununu’s vocal opposition to legalization will make it harder to join their neighbors.

„Connecticut doesn’t do enough for New Hampshire because we have one person holding it back,” Daryl Eames, the founder of the New Hampshire Cannabis Association, an advocacy group, told ABC News.

Representatives for Gov. Sununu’s office didn’t immediately return ABC News' requests for comment.

Eames said an attempt to pass legislation for recreational marijuana in 2019 couldn’t get past a veto-proof majority in the state Senate. Arguments over the lost tax revenue and, more importantly, loss business to neighboring states haven’t been enough to sway the more conservative members of the government, Eames contended.

„It’s just something that’s not in their short-term plans,” he said.

The political roadblocks are not discouraging Eames and state leaders who support legalization. He noted that more legislators on both sides of the aisle have formed cannabis caucuses and are mustering support for legalization efforts.

New Hampshire House Representative Timothy Egan, who chairs the Democratic House Cannabis Caucus, told ABC News that legalizing cannabis was critical for the state’s post-pandemic future.

„New Hampshire prides itself with independent thought and touts a state motto of Live Free or Die. Legal access to adult use cannabis grown and marketed in New Hampshire without extensive government oversight is more than a right to create small businesses, it’s seeing personal cultivation and possession as a civil right,” he said in a statement.

Eames predicted that if other states across the country continue to legalize marijuana and, most importantly, if the federal government begins discussion to reschedule the substance, the governor and state house will have no choice but to reconsider.

„It does feel bad that we could be the only state in the region to not offer it, but it’s probably going to be more of a question of when than if,” he said.

Long Island Educators And Lawmakers Sound Alarm About THC-Laced Cookies That Look Like Snack For Kids – CBS New York

LONG BEACH, N.Y. (CBSNewYork) — There is a new warning saying THC-laced cookies are anything but kid stuff.

Educators and lawmakers on Long Island are sounding the alarm, trying to close a loophole that allows the cannabis plant extract called Delta 8 to be sold legally in New York state, CBS2’s Carolyn Gusoff reported Wednesday.

They look like snacks for kids, but inside the packets there is a potent dose of THC, sold legally in the state and online.

EMT Joe Lattanzi sounded the alarm to Long Beach parents after an adult became violently ill.

“Dehydration, vomiting, low heart rate. You can have a so-called ‘high’ for 12 hours,” Lattanzi said.

READ MOREConnecticut Becomes 19th State To Legalize Recreational Marijuana

Parents say the packaging is dangerous and the products produce an unregulated and untested high.

“A serving is actually a quarter of a cookie, so if you can imagine if it got in the hands of a child and they ate the whole entire package, what that would do to a kid,” said Alexis Pace of the Long Beach School Board.

“What if your 8-year-old sees cookies and says, ‘Oh, yum.’ The effects on children can be devastating,” state Assembly member Missy Miller added.

FLASHBACK: CDB, THC In Medical Marijuana Seen As New Tool In Fight Against Opioid Addiction

Now, a call to ban the hemp extract Delta 8, which is similar but not chemically identical to marijuana.

“Under the name of Delta 8, companies are taking advantage of the loophole by putting their products in packaging that is clearly targeting children in a very dangerous way,” State Sen. Todd Kaminsky said.

They’re asking the public to flood the state Department of Health, which is now considering a ban on Delta 8 amid an uptick in accidental use across the nation.

“There is a lot of THC in this thing and it’s going to cause people to get sick,” Long Beach Police Commissioner Ronald Walsh said.

The cookies have been pulled from the shelves of one Long Beach store, with the owner saying the product was never sold to minors.

Morgan Fox, a spokesman for the National Cannabis Industry Association, said Delta 8 must be regulated — not banned — to ensure it’s safe.

“That sort of packaging only exists in the unregulated market. Every single state that has a legal adult use or medical program has very strict rules about packaging, in terms of having child-proof packaging, not being appealing to children,” Fox said.

READ MOREExclusive: CBS2 Goes Behind The Scenes At Queens Cannabis Dispensary As Medical Marijuana Use Increases During Pandemic

In a letter, lawmakers are urging swift action, arguing just as the state is formulating its marijuana industry regulations, to allow a compound so similar to marijuana to go unregulated is ridiculous and dangerous.

The public has a month and a half to contact the state health department to weigh in on Delta 8. Dozens of states have temporarily banned the substance.

Correspondence to the health department should be sent to:

NYS Department of Health
Corning Tower
Empire State Plaza, Room 2438
Albany, N.Y.

Or an email can be sent to regsqna@health.ny.gov.

The following is a statement from the state health department:

“At this point, the New York State Department of Health’s regulations are proposed and subject to public comment until July 19, 2021. After such time, the department will assess all comments and if no further changes are necessary, adopt the regulations as written, at which time the prohibition on products manufactured with Delta 8 created through isomerization will be immediately effective.”

The health department added:

  • Delta 8 THC is a derivative of cannabinoids extracted from the cannabis plant made through isomerization and is therefore not allowed in the state’s cannabinoid hemp program.
  • Delta 8 THC, similar to Delta 9 THC, can get the user high and therefore is not appropriate for the hemp marketplace. It is not banned in the medical program, nor will it necessarily be banned in the adult-use program, as that remains to be seen.

Rabon and Lee pitch medical cannabis in Senate – Port City Daily

Cannabis reform may be on the horizon in N.C. Sens. Michael Lee and Bill Rabon have joined forces with Democrats to advance a medical cannabis bill with a scrupulous regulatory framework. (Port City Daily/File)

Update: Senate Majority Leader Kathy Harrington, R-Gaston, is now a cosponsor of the Compassionate Care Act

Amid the flurry of cannabis bills North Carolina lawmakers have proposed this session — each with a unique spin on state-level weed reform — one proposal stands out with bipartisan support. Cape Fear Senators Bill Rabon, R-Brunswick, and Michael Lee, R-New Hanover, presented the N.C. Compassionate Care Act before the Senate Judiciary Committee Wednesday afternoon. 

Four Democrats have co-sponsored the bill, including Paul Lowe, D-Forsyth. The proposed legislation comes as revisions to cannabis laws sweep the East Coast and beyond. Democrats in N.C. filed bills earlier this year that would legalize cannabis medicinally and recreationally; other Republicans pushed a more cautious approach that would change N.C. cannabis laws only upon federal action. 

The Compassionate Care Act answers those other movements with a distinctive regulatory framework that would carefully introduce medical cannabis into the healthcare scene. The bill’s language enumerates a powerful gatekeeping role to be played by state level bureaucracies like the N.C. Department of Health and Human Services (NCDHHS). 

“This is the most tightly regulated and controlled bill of its type in the 36, 37 states that now have medical cannabis,” Rabon said at the committee hearing. “A couple of states have reached out to some of our friends and told them they wished theirs had been just as good.”

The backbone of the proposed oversight system lies in two advisory boards, both of which include a mix of political appointees, medical professionals and industry experts.

The Medical Cannabis Advisory Board would make decrees on the type of “debilitating conditions” that would justify a physician’s ability to prescribe medical cannabis. As it stands, at least 15 conditions would qualify an N.C. citizen for a registration card. (Read the full list at the end of this article.) 

Lee noted that the exclusion of “chronic pain” as a debilitating condition worthy of a medical cannabis prescription was a deliberate debarment — in order to prevent the gratuitous distribution of cannabis that would cause a “Wild West” effect, which he said occurred in California after medical legalization. 

Patients would pay a $50 fee to NCDHHS for their registration card, and their information would be entered into a confidential medical database accessible to  law enforcement. Prescribing doctors must complete an educational course and annual refresher courses thereafter. “Designated caregivers,” a role created previously by other states in their medicinal cannabis laws, would go through the same NCDHHS approval processes, and be authorized to assist patients with cannabis treatments. 

From left to right: Michael Lee, Paul Lowe and Bill Rabon discuss their pitch for a medical cannabis overhaul Wednesday before the judiciary committee. (Port City Daily/Courtesy NCGA)

“Bill sponsors going to great lengths to discuss how this bill is designed for medical cannabis only, clearly an attempt to assuage concerns from members of their party,” tweeted Sen. Jeff Jackson, D-Mecklenburg, during the committee hearing. 

Lee and Rabon worked to ease the distaste held by some in the GOP for any measure that could be seen as a gateway to recreational cannabis. “Some of us have a bridge we need to cross to get comfortable with this,” said Sen. Paul Newton, R-Cabarrus. “And I’m hearing you loud and clear that you have made the boundaries of this, the guardrails of this, sort of paramount in your development.”

Sen. Mujtaba Mohammed, D-Mecklenburg, implored Rabon to include in his bill a provision that would decriminalize cannabis possession in small amounts, stating that more than 60% of cannabis-related police apprehensions in N.C. have been against people of color. 

Rabon replied the Compassionate Care Act will not be expanded beyond the realm of medical cannabis. The decriminalization angle would have to stand independently in its own bill, Rabon said. Mohammed retorted he had already co-sponsored such a bill, and it currently waits to be heard in Rabon’s committee. 

A spokesperson for Attorney General Josh Stein wrote in an email: “Our office is reviewing this legislation and does not currently have a position.”

A spokesperson for the North Carolina Healthcare Association (NCHA) wrote: “NCHA has seen the bills and we do not have a stance on cannabis legalization for either medicinal or recreational uses.”

“To receive medical cannabis, there are a lot of hoops that patients will have to jump through,” Rabon told the judiciary committee.

WPD's Special Investigation Division ended a two-month narcotics investigation, resulting in the seizure of drugs, money and firearms. (Port City Daily photo/COURTESY OF WILMINGTON POLICE DEPARTMENT)
Proponents of medical cannabis argue it would allow those afflicted with debilitating medical conditions a better quality of life. Opponents see medical cannabis as a gateway to full legalization, or in some cases, as junk science. Pictured above: fruits of a 2018 Wilmington Police drug bust (Port City Daily/File)

The Medical Cannabis Production Commission would handle the business and product ends of the cannabis landscape. The bill emphasizes that the plants shall be grown in N.C. 

Applicants for a medical cannabis supplier license face a steep hill to climb if the bill were to become law. The number of suppliers statewide will be capped at 10, and each of those entities will be responsible for seed-to-sale oversight. All 10 license-holders must own both a production facility and dispensary, and are limited to eight dispensaries each. (Suppliers will place at least two of their dispensaries in Tier 1 counties, a Department of Commerce designation for the state’s 40 most economically distressed counties.)

“We took some pieces of puzzles from other bills that we had seen in this legislature, and then really kind of put our own spin on it,” Lee told his fellow senators. “Because we really couldn’t pull anything from other states.” 

Suppliers will pay a $50,000 license fee to NCDHHS, and a $10,000 annual renewal fee. NCDHHS also gets a 10% cut of all gross revenues. 

The dispensaries will be subject to strict land-use and marketing reviews; no cartoonish imagery, attempts at humor, scintillating packaging or even depictions of marijuana leaves will be permitted. The goal is for the cannabis centers to blend into business districts. 

There is a provision requiring five years experience in the legal medical cannabis world, meaning out-of-state consultants and businesses will be leaned on heavily at the outset. 

“We’re on a crash course with federal legalization in my opinion,” said Axel Owen, the campaign manager for a New Jersey recreational cannabis ballot referendum overwhelmingly approved in November 2020. Vast swaths of the country put cannabis friendly laws on the books throughout the past two decades. Often there’s a trajectory, Owen said, in which states move from medicinal to recreational legalization. But in some cases medical-approved states sit idle without movement forward on the recreational cannabis front.

“We wanted to roll out the program that we wanted to see in New Jersey, and let New Jerseyites make that decision rather than having the federal government make that decision for everyone,” Owen said.  

Owen said if states reform cannabis laws prior to federal action, they’ll be able to retain more control over their marketplaces and regulations when and if the federal move occurs. 

“By North Carolina going earlier, it gives them the ability to set the parameters and the discussion of how this is going to be rolled out, rather than having the federal government come in and say ‘these are now your parameters,’” Owen said. 

He added that he faced opposition from Smart Approaches to Marijuana, an anti-legalization advocacy group. During the committee hearing Wednesday, Lee said the same group had been active in opposing the Compassionate Care Act. 

The Compassionate Care Act sat untouched in Rabon’s rules and operations committee for two months before a proposed committee substitute version earned the spotlight before the judiciary committee Wednesday in an informational hearing. If considered favorably at a future hearing, from there the bill would proceed to other committees, including finance, then healthcare, then back to Rabon’s rules and operations, before finally hitting the Senate floor. 

“Bill is set to go through four committees. That’s as many as I’ve ever seen a bill go through,” Democrat Jeff Jackson tweeted. “That means this is being handled with extreme caution by the majority. Passage is by no means a foregone conclusion.”

This is the list of conditions that would allow one to procure a medical cannabis prescription pursuant to the Compassionate Care Act. The Medical Cannabis Advisory Board would have the power to add new conditions to the list with a majority vote. “Chronic pain,” was deliberately excluded from the list. (Port City Daily/Courtesy NCGA)

Send tips, comments and criticisms to preston@localdailymedia.com

Print Friendly, PDF & Email

CBDfx Launches CBD-Infused Pet Balm As Pet CBD Industry Continues to Skyrocket – PRNewswire

„Pet paws and noses can be particularly sensitive; whether in response to weather changes or even allergies,”said Jameson Rodgers, Co-Founder. „Our new Calming & Moisturizing Balm not only soothes the pain that accompanies dry and cracked skin, but also moisturizes and protects the skin so that it can heal. Our goal with our CBD for Pets line is to help as many pets as possible to live their best lives, and this all-natural balm is the perfect complement to our vegan CBD Pet Treats and CBD Oil for Pets.”

CBDfx’s Calming & Moisturizing CBD Pet Balm is made with 750mg organic broad spectrum CBD, odorless Alaskan salmon oil to promote healthy skin and coat, hydrating shea butter, plant-based Candelilla wax, and active botanicals known for their healing properties. This soothing balm helps soothe aches and pains, relieve hot spots, and calm nervous or anxious pets by applying a small amount to the affected area and gently massaging it into the skin. Retailing at $39.99 for a 2 oz. tin, the all-natural balm contains the same trusted and high-quality hemp-derived cannabidiol that CBDfx uses for all of its human CBD products and follows the brand’s standard approach to transparency with a QR code linking to the corresponding lab report.

The Calming & Moisturizing CBD Pet Balm joins CBDfx’s vegan Pet Treats in two variations targeting anxiety and joint health, and their full line of vegan CBD Oil for Pets. With the 4th of July and the accompanying fireworks just around the corner, many pet parents are looking to CBD as a natural way to help calm frazzled nerves.

CBDfx also continues to support pets through the brand’s Search Dog Fundraising bundle through June 30, with 100% of profits donated to Search Dog Foundation, and its Welcome Home gift to make pets' transition from shelter to forever home as stress-free as possible.

Learn more about CBDfx and shop all CBD Products for Pets at www.cbdfx.com.

About CBDfx: CBDfx is a Southern California-based company founded on providing high quality, organically sourced hemp-derived cannabidiol (CBD) wellness products to customers in a wide variety of formats; from tinctures to topicals, and gummies to capsules. Founded in 2014 with a mission to push quality to the forefront of the CBD industry, CBDfx continues to provide some of the finest, purest, and most effective CBD products in the world. CBDfx products are sold in more than 32,000 points of distribution in 21 countries, and online at www.CBDfx.com.

Lauren Josey
Senior PR Manager
[email protected] 


Related Links


2021 Pocono Organics CBD 325 odds, picks: Surprising NASCAR predictions, leaderboard from proven model – CBS Sports


The NASCAR Cup Series will return to Pocono Raceway for back-to-back races this weekend, and the action starts on Saturday with the 2021 Pocono Organics CBD 325. The 2.5-mile asphalt triangle is one of the most unique challenges of the season, with sharp corners and low banking making the venue feel like a road course. It’s a design that has suited current points leader Denny Hamlin well, as he’s collected six victories at Pocono in his career.

Hamlin is listed at 13-2 in the latest 2021 Pocono Organics CBD 325 odds from William Hill Sportsbook. However, Kyle Larson is the 9-4 favorite in the 2021 NASCAR at Pocono odds after winning each of the last four races on the NASCAR schedule, including the All-Star Race. Other top 2021 Pocono Organics CBD 325 contenders include Kyle Busch (7-1), Kevin Harvick (7-1) and Chase Elliott (8-1). The green flag drops at 3 p.m. ET. Before scouring the 2021 Pocono Organics CBD 325 starting lineup and making any NASCAR at Pocono predictions, be sure to see the latest 2021 Pocono Organics 325 picks from SportsLine’s proven projection model.

Developed by daily Fantasy pro and SportsLine predictive data engineer Mike McClure, this proprietary NASCAR prediction model simulates every race 10,000 times, taking into account factors such as track history and recent results.

The model began the 2020 season paying out big by picking Denny Hamlin to win his second consecutive Daytona 500 at 10-1. The model also called Kevin Harvick’s win at Atlanta and nailed a whopping nine top-10 finishers in that race. McClure then used the model to lock in a 10-1 bet on Hamlin for his win at Miami.

At The Brickyard, the model called Harvick’s fourth victory of the season. Then during the 2020 NASCAR Playoffs, the model nailed its NASCAR picks in back-to-back races, calling Denny Hamlin to win at 17-2 at Talladega and Chase Elliott to win at 7-2 at the Charlotte Roval.

In the 2021 season, the model has correctly predicted at least seven top-10 finishers in seven of the last 14 races. In April, McClure nailed Martin Truex Jr. to win at Martinsville for a strong 3-1 payout. The model also nailed Kyle Larson winning the NASCAR All-Star Race at 5-2 and hit Larson again at the Ally 400 for another 5-2 payout. Anyone who has followed its lead on those plays has seen huge returns.

Now, the model simulated the 2021 Pocono Organics CBD 325 10,000 times. Head to SportsLine to see the complete projected NASCAR at Pocono leaderboard.

Top 2021 Pocono Organics CBD 325 predictions

One surprise: the model is high on Martin Truex Jr., even though he’s a 15-1 long shot in the latest NASCAR at Pocono odds 2021. He’s a target for anyone looking for a huge payday. Truex is coming up on his 41st birthday next week, but he’s still going strong, with three wins already this season to give him 30 career Cup victories.

Two of those career wins have come at Pocono Raceway, as he took the checkered flag at the 2018 Pocono 400 and 2015 Axalta „We Paint Winners” 400. Truex is also working on a streak of three consecutive top-10 finishes at Pocono, while his six top-five finishes this season have come on a variety of surfaces.

And a massive shocker: Elliott, one of the Vegas favorites at 8-1, stumbles and fails to crack the top five. There are far better values in this loaded 2021 Pocono Organics 325 field. The defending NASCAR Cup Series champion slipped to fourth in this year’s standings after being disqualified for five loose lug nuts last week in Nashville.

Elliott does have seven career top-10 finishes in 10 starts at Pocono in the Cup Series, but he’s finished 25th or worse in two of his last three starts on the Tricky Triangle. He’s also had four finishes outside the top 20 already this season. Given that he’s never won at Pocono, the price appears too steep for the talented young star.

How to make 2021 NASCAR at Pocono picks

The model is also targeting two other drivers with 2021 NASCAR at Pocono odds longer than 15-1 or longer to make a serious run at winning it all. It also sees value in a massive long shot who’s almost 200-1. Anyone who backs these drivers could hit it big. You can see all of the model’s NASCAR picks over at SportsLine.

So who wins the Pocono Organics CBD 325 2021? And which 175-1 long shot is a shocking value this week? Check out the latest 2021 NASCAR at Pocono odds below, then visit SportsLine now to see the full projected 2021 Pocono Organics CBD 325 leaderboard, all from the model that has nailed Kyle Larson’s wins the last two weeks

2021 Pocono Organics CBD 325 odds

Kyle Larson 9-4
Denny Hamlin 13-2
Kevin Harvick 7-1
Kyle Busch 7-1
Chase Elliott 8-1
William Byron 10-1
Joey Logano 12-1
Brad Keselowski 15-1
Martin Truex Jr. 15-1
Ryan Blaney 15-1
Alex Bowman 18-1
Kurt Busch 25-1
Aric Almirola 30-1
Christopher Bell 50-1
Tyler Reddick 60-1
Ricky Stenhouse Jr. 75-1
Erik Jones 75-1
Ross Chastain 75-1
Matt DiBenedetto 100-1
Ryan Newman 150-1
Austin Dillon 175-1
Bubba Wallace 200-1
Chris Buescher 200-1
Cole Custer 250-1
Daniel Suarez 300-1
Chase Briscoe 750-1
Ryan Preece 750-1
Michael McDowell 1000-1
Corey Lajoie 5000-1
Timmy Hill 5000-1
Josh Bilicki 5000-1
BJ McLeod 5000-1
Justin Haley 5000-1
Cody Ware 5000-1
Anthony Alfredo 5000-1
James Davison 5000-1
Quin Houff 5000-1
Garrett Smithley 5000-1

When and why: The CBD debate – DVM 360

Cannabidiol (CBD) and tetrahydrocannabinol (THC) are fairly hot-button topics in veterinary medicine that are difficult to unpack, with no distinguishable gray area—or so I thought. Historically, I always seem to encounter either the die-hard “holistic” believers or their antipode, the “gold standard Western medicine practitioners.” However, in recent years I have learned there are many “closet supporters” of CBD who find it difficult to openly endorse as a legitimate treatment modality because of either lack of clinical understanding or fear of legal ramifications.

As a CBD user who has experienced quantifiable results, I firmly believe there is a place for CBD in veterinary medicine that does not have to be limited to holistic practices. After all, anyone working in emergency medicine is likely familiar with Yunnan Baiyao, a traditional Chinese medicine used in hemorrhagic cases for its presumed hemostatic qualities. All that being said, this is my attempt at addressing the CBD debate.

Cannabis: A basic understanding

To understand when and why CBD is appropriate to discuss or use in veterinary medicine, we must first understand what it is. This requires a general understanding of the cannabis plant. CBD and THC are phytocannabinoid derivatives of the cannabis species.1 Cannabis is an umbrella term for any hemp or marijuana plant with a THC concentration that has not been quantified; marijuana is cannabis with a determined THC concentration greater than 0.3%; and hemp is cannabis or any part of the plant with a determined THC concentration less than 0.3%.2 The Cannabaceae family can be broken down into the species Cannabis sativa and subspecies Cannabis indica and Cannabis ruderalis.2

Although the cannabis community has created a perception that one species is known for higher concentrations of THC over CBD and vice versa, concentrations of either can vary by species and the chemical makeup is greatly affected by how the particular strain is grown. In actuality, the differences between the species largely come down to where the plant originated and the general appearance (eg, plant size and leaf shape).3

The endocannabinoid system

As mentioned, CBD is a phytocannabinoid, which acts on the endocannabinoid system (ECS). The ECS exists within humans and animals, vertebrates and invertebrates alike, and regulates functions in nearly every organ system throughout the body. It consists of G protein-coupled cell-membrane receptors and endogenous cannabinoid ligands, commonly referred to as endocannabinoids.2 The receptors most important in understanding the use of cannabis in medicine are cannabinoid receptors 1 and 2 (CB1R and CB2R). CB1R is found mainly within the central and peripheral nervous systems with some general distribution throughout the body, whereas CB2R is found mainly within the immune system.4

Canines specifically have been found to have a greatly increased number of CB1R within the cerebellum and brain stem compared with humans, which due to the preferential binding of THC to these receptors accounts for the pronounced clinical signs that we see with marijuana toxicosis.5 CBD interacts with receptors quite differently than THC does.

CBD has a weak affinity for receptors but can cause some antagonist activity at CB1R and inverse agonist activity at CB2R.4 In humans, this inverse agonist activity has been shown to reduce some of the psychoactive adverse effects (AEs) of THC when used in conjunction with CBD, and is known as the entourage effect.5 In veterinary medicine, THC is not a treatment option, but that does not mean CBD cannot be.

The evidence

We know what CBD does on a chemical level, but what is important is the quantifiable response to consistent use. The FDA has only approved 1 cannabis-derived CBD product for use in human medicine. Epidiolex is used to control seizure episodes associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.6 In clinical trials, it showed an average reduction of seizure activity across the 3 syndromes by 39% to 48% over 14- to 16-week periods.6 Outside of prescription use, CBD users tout it for its benefits in controlling pain, appetite and nausea, anxiety and depression, and insomnia, just to name a few. I personally have experienced benefits in controlling chronic pain, anxiety, and shift work-related insomnia. With all of the clinical and anecdotal evidence available in human CBD use and the knowledge that animals have an endocannabinoid system akin to humans, it is fairly reasonable to assume that the benefits of use in veterinary medicine would be similar to those we experience. However, exploration of CBD in veterinary medicine did not gain popularity until very recently.

There have only been a handful of CBD studies in animals, with most of the focus on epilepsy and osteoarthritis. Two notable studies are those conducted by Colorado State University (CSU) and Cornell University. The study conducted by CSU involved the use of CBD to treat canine epilepsy. Although it was a small-scale study, the results were promising with 90% of participants experiencing a decrease in seizure activity7 and a median reduction in seizure activity of 33%.8

The Cornell study addressed canine osteoarthritis and results showed a reduction of pain and improved mobility in over 80% of the participants, suggesting CBD to be an appropriate adjunct therapy in the treatment and management of osteoarthritis.9 In both these studies, minimal AEs were noted with the most significant being an increase in serum alkaline phosphatase.9,10

A safety study conducted by Canopy Animal Health also indicated that CBD oil is well tolerated in canines, with over 94% of AEs scored as mild and mainly involving gastrointestinal signs and elevated serum alkaline phosphatase.10 Unfortunately, there is limited study data available on the safety and efficacy of CBD use in felines.

Legality of use in veterinary medicine

As proven in multiple studies, CBD can be an effective, safe therapy for many animals, which begs the question of why more veterinarians are not recommending it. Until very recently, CBD was classified as a Schedule I drug under the Controlled Substances Act (CSA) and therefore federally illegal. The passing of the Agricultural Improvement Act of 2018, known popularly as the 2018 farm bill, removed hemp and hemp-derived products from the definition of marijuana, thereby declassifying it as a scheduled substance under the CSA so long as the plant and products contain less than 0.3% THC.11 However, the hemp bill preserved the United States Food and Drug Administration’s right to regulate any cannabis and cannabis derivatives under the Food, Drug, and Cosmetic Act,11 meaning veterinarians cannot legally prescribe CBD as a treatment protocol and must use diligence when discussing its use with clients.

Additionally, although CBD is now legal at the federal level, there are still 8 states with restrictions regarding sales and use,12 which adds another layer of complexity when considering its use in veterinary medicine. The only way to safely discuss CBD with a client is to refrain from stating that it is a drug that can treat or cure any particular illness. As with any other unregulated supplement or nutraceutical, the loophole exists wherein we can discuss how it can “support” a particular bodily system or function.

The debate

As part of my own research, I recently polled peers, veterinarians, technicians, and assistants to learn their opinions regarding CBD. I asked 2 questions: Do you believe CBD has a future in veterinary medicine, and why or why not? The responses were overwhelmingly in favor of CBD, feeling that “it can’t hurt and might help.” Some of my peers already use CBD for their own animals mostly for its anxiolytic effects and to support mobility and appetite; a few had experience with successful use in epileptic cases in animals whose seizures were poorly managed with multiple anticonvulsant medications. One person had no opinion in either direction due to lack of experience with it. One was firmly against its use, citing a study suggesting no legitimate benefit in patients with epilepsy and concern about misuse at the hands of owners.

Despite the opinions that CBD does have a future, the support comes with stipulations. The primary concern is that there needs to be appropriate training provided to veterinary professionals and equivalent education to owners to prevent misuse; for example, an owner intentionally using a product containing THC, causing a toxicity case. Having seen a large increase in marijuana ingestion cases following the legalization of recreational use in my state, I tend to agree that the risk increases without proper education. The other concerns surround the potential for owners to put all their hope on CBD as a replacement for Western medicine, the fear of legal repercussions for veterinarians, and the stark lack of supporting clinical evidence.

Considering all the current information on CBD use in human medicine, the beginnings of research in veterinary medicine, and the changes in legality, I strongly believe it has a future in our field. I did not previously subscribe to the hype and I would refuse to discuss the topic with clients or owners who were seeking support and approval for their decisions to experiment with CBD. But like the field, I have evolved and transitioned from my previously adamant no to a willingness to discuss without making recommendations. Now, I can safely say I am ready to openly advocate for its use if it can improve the quality of life for our patients.

I have found that most clients interested in the properties of CBD are pursuing it as a last-ditch effort, frequently as an adjunct therapy in hospice care or to mitigate the AEs of chemotherapy treatment. These owners have nothing left to lose but their animal companions. They, as well as all pet owners, deserve the opportunity to discuss other options. We exist in this profession for the betterment of our patients and their owners; we have an obligation to seek new and better therapies and right now that means we need to focus more attention on CBD research. For me, there is no debate. I am “Team CBD” all the way.

Janelle Overholser, CVT, is an ICU veterinary technician for BluePearl Specialty and Emergency Pet Hospital. She is a graduate of Penn Foster College and recently returned to school to obtain her BAS degree in veterinary technology. She is passionate about emergency medicine and is pursuing her VTS in ECC.


  1. Compound summary: cannabidiol. National Center for Biotechnology Information. Updated June 19, 2021. Accessed May 6, 2021. https://pubchem.ncbi.nlm.nih.gov/compound/Cannabidiol
  2. American Veterinary Medical Association. Cannabis in veterinary medicine. August 2020. Accessed May 6, 2021. https://www.avma.org/sites/default/files/2021-03/APH-CannabisResources-Report-20201207.pdf.
  3. Indica vs. sativa: understanding the differences between weed types. Leafly. September 20, 2018. Accessed May 5, 2021. https://www.leafly.com/news/cannabis-101/sativa-indica-and-hybrid-differences-between-cannabis-types
  4. Silver RJ. The endocannabinoid system of animals. Animals. 2019;9(9):686. doi:10.3390/ani9090686
  5. The entourage effect: How CBD and THC work together. Healthline. Accessed May 7, 2021. https://www.healthline.com/health/the-entourage-effect
  6. Epidiolex. Greenwich Biosciences. Accessed May 13, 2021. https://www.epidiolex.com/about-epidiolex
  7. McReynolds T. New study: CBD shows promise for treating canine epilepsy. NEWStat. May 30, 2019. Accessed May 13, 2021. https://www.aaha.org/publications/newstat/articles/2019-05/new-study-cbd-shows-promise-for-treating-canine-epilepsy/
  8. McGrath S, Bartner LR, Rao S, Packer RA, Gustafson DL. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. J Am Vet Med Assoc. 2019;254(11):1301-1308. doi:10.2460/javma.254.11.1301
  9. Smith D. Cornell University study says hemp oil works for dogs in pain. Cannabis.net. February 14, 2018. Accessed May 12, 2021. https://cannabis.net/blog/medical/cornell-university-study-says-hemp-oil-works-for-dogs-in-pain
  10. Vaughn D, Kulpa J, Paulionis L. Preliminary investigation of the safety of escalating cannabinoid doses in healthy dogs. Front Vet Sci. 2020;7:51. doi:10.3389/fvets.2020.00051
  11. FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD). FDA. Updated January 22, 2021. Retrieved May 1, 2021. https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#farmbill
  12. Keehn J. CBD laws by state 2020 – just the facts [is CBD legal in 2020?]. CBD School. Updated February 23, 2021. Accessed May 12, 2021. https://www.cbdschool.com/cbd-laws-by-state-2020/

Swade Cannabis to debut their Delmar cannabis dispensary — Greenway Magazine – Greenway

BeLeaf Medical’s Swade Cannabis brand will open its second  location in the city, on the Delmar Loop, June 24, 2021 to Missouri medical card holders. Come  by and meet the street team, find out how to get a medical card, check out the Swade and Arch  Apparel collaboration, find out more about 314Twenty and visit the gorgeous renovated church  that is home to the newest Swade Dispensary. The first 50 customers will receive a penny  prepack with any cannabis purchase. 

Swade has already opened three of their five dispensaries in the area and will continue to carry  the largest and most diverse variety of medical cannabis produced in the state. “Our  dispensaries are tailored to create an atmosphere that is open and inviting with a premium  experience for the educated and yet – to- be – educated patient. We want you to feel comfortable  in our dispensary and will help you find the perfect product and strain to meet your needs,”  commented Jack Haddox, Director of Dispensary Operations. “You will find flower, edibles,  beverages and other medical forms of product at our locations with more options arriving  daily.”  

The Swade Dispensary in the Delmar Loop will host a Grand Opening and ribbon cutting later  this summer but we know the need for medical cannabis with locations that will reach the  masses is paramount. 

“Education is so important – we understand that there are many questions and much confusion  around medical cannabis and we are focused on delivering an exceptional experience and will  provide patients with the highest quality of medical marijuana in the state,” said Tom Muzzey,  


CEO of Beleaf Medical. “Patients deserve easy, convenient access to the life-changing medicines  that improve their lives and we are honored to be able to provide this with medical cannabis  AND education in The Delmar Loop no less.”  

Need help or have questions about getting a medical card? Stop in and get assistance to make  the process seamless. 

ABOUT SWADE: Swade is Missouri’s premiere luxury cannabis company created to restore and 

enliven mind, body, and spirit. SWADE takes a holistic approach to cannabis, creating a  premium experience from our elevated dispensaries to the lasting sensory impression of our  products. SWADE offers an inviting atmosphere, informative approach and a love for precision  in premium cannabis. Additional photos available upon request. ###

Lawmakers, school officials rally against THC compound-infused snacks – News 12 Long Island

A group of lawmakers, school officials and parents rallied outside Long Beach City Hall to urge the state to ban the THC compound used in snacks being sold on the South Shore.

Concerns have been rampant over the snacks, which look very similar to classic cookies, but actually contain a THC compound in marijuana.

For example, instead of Chips Ahoy, one package says Trips Ahoy, and the popular Oreos are packaged as Stoneo.

One serving size is just a fourth of a tiny cookie, and health experts have warned that it could lead to poisoning in kids if they get their hands on it.

Because the cookies are made from a slightly different compound that comes from hemp, they’re technically legal right now.

Suffolk Police Commissioner Stuart Cameron says when they were made aware that the products were being sold locally, they went to all CBD dealers. The products were found at one shop but were already taken off shelves because an adult customer had a bad reaction to it.

A warning came in a message to families from the Long Beach superintendent, who wrote, „I am sure you are as horrified as I am at the way these are obviously targeting children and young people. My nightmare is that young children might consume these without even realizing what they are.”

Addiction specialist Jeffrey Reynolds, with Family and Children’s Association, says products like these are especially harmful to children.

„When we’re talking about children, we’re talking about developing brains,” says Reynolds. „We’re talking about developing body parts and organs, and the possibility of poisoning is very significant. The possibility of long-term damage is in the mix.”